Skip to main content
. 2015 Oct;3(10):761–768. doi: 10.1016/S2213-2600(15)00320-3

Table 1.

Baseline characteristics

NRT (n=106 759) Bupropion (n=6557) Varenicline (n=51 450)
Age (years) 40·4 (13·6) 37·7 (11·1) 38·1 (11·5)
Female sex 55 345 (52%) 3172 (48%) 24 686 (48%)
Socioeconomic status* 3·2 (1·4) 2·9 (1·3) 3·0 (1·3)
Chronic obstructive pulmonary disease 12 112 (11%) 427 (7%) 4140 (8%)
Diabetes 7415 (7%) 229 (3%) 2511 (5%)
Peptic ulcer disease 3334 (3%) 136 (2%) 1243 (2%)
Renal disease 4618 (4%) 170 (3%) 1457 (3%)
Rheumatological disease 3001 (3%) 106 (2%) 1059 (2%)
Cancer 4311 (4%) 159 (2%) 1449 (3%)
Alcohol misuse 8713 (8%) 321 (5%) 2932 (6%)
Previous ischaemic heart disease 6098 (6%) 175 (3%) 1791 (3%)
Previous cerebral infarction 3477 (3%) 97 (1%) 852 (2%)
Previous heart failure 854 (1%) 19 (<1%) 186 (<1%)
Previous peripheral vascular disease 1354 (1%) 42 (1%) 412 (1%)
Previous arrhythmia 2335 (2%) 85 (1%) 659 (1%)
Previous depression 40 255 (38%) 2215 (34%) 16 242 (32%)
Previous self-harm 12 043 (11%) 610 (9%) 4621 (9%)

Data are mean (SD) or n (%). NRT=nicotine replacement treatment.

*

Townsend Index: 1 (lowest level of deprivation) to 5 (highest level of deprivation).41